ISPOR COMMENTS ON PROPOSED EUROPEAN UNION COOPERATION ON HEALTH TECHNOLOGY ASSESSMENT

Published Jan 24, 2017

Society’s Comments Emphasize Need for Ongoing Collaboration and Observation of HTA Good Practices

  Princeton, NJ—January 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has submitted comments in response to the European Commission’s request for public consultation regarding the issue of European Union (EU) cooperation on health technology assessment (HTA). ISPOR formulated its response with input from and on behalf of its members. The European Commission has requested input regarding the future of this initiative following the conclusion of EUnetHTA Joint Action 3 in 2020 that seeks to define and implement a sustainable model for the scientific and technical cooperation on HTA in Europe. Under consideration are options for the establishment of a permanent EU structure for voluntary or mandatory cooperation in the production and utilization of joint HTA reports. In summary, ISPOR’s comments emphasize that ongoing EU collaboration after 2020 will still be necessary to continue the efforts of EUnetHTA’s Joint Action 3 and to help adapt to scientific advances and changing societal needs. While the Joint Actions have helped to create greater consistency across the EU Member States’ approaches to HTA, ISPOR believes that considerable differences still exist between the EU countries’ deployment of HTA. ISPOR’s comments noted that several HTA good practices can be more effectively utilized by the Member States. To facilitate and inform this process, the Society has published more than 60 member-driven Good Practices for Outcomes Research Task Force Reports on HTA-relevant topics. ISPOR believes that fostering awareness of and observance to best practices in outcomes research and HTA is in the best interest of both individual patient populations and society as a whole. The full text of ISPOR’s response can be found here. Additionally, all public responses will ultimately be made available on the European Commission’s public consultation website. The Society’s comments were formulated through considerable member input. Using a subset of the full questionnaire used by the EU for the public consultation, ISPOR fielded an online survey of its members to generate input on this important issue. The survey generated robust responses representing all sectors of the Society’s membership, with a slightly higher response from European-based members. ISPOR collaborated with four of its councils (i.e., Health Science Policy Council, Health Technology Assessment Council, Institutional Council, and Faculty Advisor Council) to coordinate member input and develop the Society’s formal response.

###

 

Related Stories

ISPOR Announces 2025-2026 Board of Directors

May 20, 2025

ISPOR announced the results of its recent elections and its 2025-2026 Board of Directors. The 2025-2026 board will assume office on July 1.

Value in Health Journal Spotlights "Whole Health" in Special Series

May 19, 2025

Value in Health, the official journal of ISPOR, announced the publication of a series of articles exploring the concept of "whole health"—a holistic approach to healthcare that extends beyond the traditional biomedical model to incorporate physical, mental, social, environmental, and spiritual dimensions of wellbeing.

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×